Active	Status	Sponsor type	Region	Phase	Filter
2 Active 9 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ratain, Mark J
NCT04295863: Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers	Recruiting	1	264	US	Nivolumab Standard, Pembrolizumab Standard, Nivolumab Extended, Pembrolizumab Extended	University of Chicago	Metastatic Cancer	04/25	04/25
NCT05166694: Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions	Recruiting	N/A	1300	US	Drug-Drug Interaction Profile, Drug-Gene Interaction Profile, Standard of Care	University of Chicago	Cancer, Advanced Cancer, Advanced Solid Tumor, Mental Health Issue, Behavior Disorders	11/27	11/27